Article
Aberrant expression of p16INK4a in human cancers – a new biomarker?
1 Jan 2018
Abstract excerpt
tumor suppressive protein can thus be used as a biomarker to detect early stage cancer cells as well as advanced tumor cells with pRB inactivation since it is not expressed in normal cells.
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
